As per the new research report by RNCOS, “Global Insulin Delivery Devices Market Forecast to 2017”, the US is the biggest market for insulin delivery devices across the globe. According to International Diabetes Federation (IDF), over 24 Million people had diabetes in US, of which around 6.6 Million were undiagnosed cases. Our research suggests that over 7 Million of the diagnosed cases, managed diabetes through insulin therapy, representing a huge patient base, which is forecasted to grow significantly by 2017.
In 2012, the market for insulin delivery devices stood at approximately US$ 4.4 Billion and is forecasted to grow at a double-digit CAGR during 2012-2017, showcasing good opportunity for players in the business. Players need to be wary of market barriers though, primary challenge being consumer preference for delivery devices. The US represents a unique trend towards the choice of insulin delivery devices, the knowledge of which is indispensable for players.
The report provides an in-depth research and rational analysis of the current status and future prospect of the insulin delivery system market. The study presents a global picture about prevalence of diabetes and the overall market for insulin delivery systems. It includes a geographical analysis of insulin delivery systems in key diabetic countries. The research further covers the market for main insulin delivery systems along with their current and future projections.
Our study leads to the proposition that innovation has huge scope in this field and we have advertently elaborated some of the emerging insulin delivery devices. Finally, an analysis of the leading market players provides a holistic understanding to the reader. Players covered include Novo Nordisk, Eli Lilly, Sanofi-Aventis, Medtronic, Roche, Becton, Dickinson and Company who together account for more than 90% of the global market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM494.htm
Some of our Related Reports are:
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)
- Genetic Testing Market Outlook to 2017 (http://www.rncos.com/Report/IM492.htm)
- Analysis of Coronary Stent in US (http://www.rncos.com/Report/IM489.htm)
- US Healthcare IT Market Outlook to 2017 (http://www.rncos.com/Report/IM487.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.